Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
These re-agent and diagnostic test kits come with 99.7% accuracy
Marks remarkable acceleration in innovation using AI technology
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Subscribe To Our Newsletter & Stay Updated